Colorcon Ventures Invests in Vedanta Biosciences, a Clinical-Stage Microbial Therapeutics Company

  • Created
    Thursday, 22 February 2024
  • Created by
    Dan Taylor
  • Last modified
    Thursday, 22 February 2024
  • Revised by
    Dan Taylor
  • Categories
    Press Releases